KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors - nejm.org

KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors  nejm.orgAmgen drug shrinks tumors in lung cancer patients with KRAS gene mutation - study  Yahoo NewsESMO: Amgen's KRAS drug tackles 32% of lung cancers—and this is just the beginning  FierceBiotechDurable responses seen with Amgen's KRAS-blocking cancer drug  STATEsmo 2020 – Kras cools off  VantageView Full Coverage on Google News